Exenatide: a new option for the treatment of type 2 diabetes
There are currently threeFDA-approved semaglutideproducts: As the world's first and currently onlyweekly glucagon-like peptid-1 receptor agonist (GLP-1RA) formulation forlong-term weight management, Semaglutideweight loss achieves an average weight loss of 17% (16.8kg) and providespatients with multiple health benefits beyond weight loss
12 To spot whether Ozempic is counterfeit, FDA encourages patients and healthcare providers to double-check Ozempic boxes, which might have spelling errors, and the batch number on the box may not match the product strength stated on the same box and pen
Because semaglutide has a half-life of roughly one week, it takes approximately five weeks to clear from the system
Clinical criteria Anthem evaluates Anthem uses specific clinical criteria to determine whether a GLP-1 prescription meets their definition of medical necessity
Savings Programs for Wegovy and Zepbound The manufacturers of Wegovy and Zepbound offer savings programs, and information about signing up is available on their websites